Fouad Ben Sudrik

Title: Fouad Ben Sudrik: Innovator in Non-Alcoholic Steatohepatitis Diagnosis

Introduction

Fouad Ben Sudrik is a notable inventor based in Lille, France. He has made significant contributions to the field of medical diagnostics, particularly in the area of non-alcoholic steatohepatitis (NASH). With a total of 2 patents to his name, his work is paving the way for advancements in the diagnosis and treatment of liver diseases.

Latest Patents

Fouad Ben Sudrik's latest patents focus on innovative methods for diagnosing non-alcoholic steatohepatitis. The first patent describes a novel method for diagnosing NASH and classifying subjects as potential candidates for treatment. The second patent outlines a method for evaluating the activity, stage, or severity of NASH using circulating miRNAs and other blood markers of liver damage. This includes markers such as alpha 2 macroglobulin, HbA1c, and specific miRNAs. Additionally, the patents include a kit for implementing these diagnostic methods and compounds for treating NASH.

Career Highlights

Fouad is currently associated with Genfit, a company dedicated to developing innovative solutions for liver diseases. His work at Genfit has been instrumental in advancing the understanding and treatment of NASH. His contributions are recognized within the medical community, and he continues to push the boundaries of diagnostic technology.

Collaborations

Fouad collaborates with talented professionals such as Raphaël Darteil and Geneviève Cordonnier. Their combined expertise enhances the research and development efforts at Genfit, fostering an environment of innovation and discovery.

Conclusion

Fouad Ben Sudrik is a pioneering inventor whose work in the diagnosis of non-alcoholic steatohepatitis is making a significant impact in the medical field. His patents and collaborations are essential in the ongoing fight against liver diseases.